Home›Search›Acta Materia Medica

Acta Materia Medica

Compuscript Ltd · Ireland · Est. 2022

ISSN2737-7946

SJR Q1✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q178

✓ Corroboration (1 more)+6

Total84

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

1.133

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Worksi

157

Total Citationsi

1,515

2yr Mean Citednessi

2.94

Open Impact Factor alternative

Aims & Scope

Acta Materia Medica provides an open platform for rapid publication of the latest findings, approaches, and viewpoints related to all related areas of pharmacy and pharmaceutical sciences, including, but are not limited to, pharmacology, toxicology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics and pharmacy management. Coverage includes: •Pathophysiology of important diseases and disease vectors • Novel therapeutic strategies • Novel methodologies facilitating the search for therapies • High-throughput screening, combinatorial chemistry, parallel synthesis and library design • 3D Structures and functions of therapeutic targets • Structural biological studies of relevant ligands and targets • Discovery, design and synthesis of biologically active agents, including natural products, therapeutic macromolecules • Drug delivery • ADME/Toxicology • Advances in key compound classes and therapeutic areas • Omics in pharmaceutical sciences • Biological databases, web-based software for pharmaceutical sciences • Studies of biological activity or mode of action. • Structure-activity correlations of drugs • Development of new imaging and diagnostic tools • Computational studies the SAR of compounds, target informatics • Business strategy for pharmaceutical industry • Clinical research and trials,  meta-analysis •Management, commercial and regulatory issues in pharmaceutical R&D. • Other aspects of pharmacy and pharmaceutical sciences.

General Information

Country / RegionIreland

Primary LanguageEnglish

1st Year Published2022

Annual Volume~ 37 articles / year

StatusActive (last: 2026)

Total Publications157

OA Since2021

Visit Journal Website

Submission Info

APC Cost💎 Diamond OA — Free

Peer ReviewSingle-blind

Review Time~13 weeks

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✗ No

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Compuscript Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2737-7946

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

No APC (Free)

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

800

2022

499

2023

193

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Complementary and Manual TherapyQ1

Inorganic ChemistryQ1

Occupational TherapyQ1

PathophysiologyQ1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Molecular MedicineQ2

Subject Classification

Scopus Categories

Inorganic ChemistryPathophysiologyPharmacology, Toxicology and Pharmaceutics (miscellaneous)Molecular MedicineComplementary and Manual TherapyOccupational Therapy

Research Topics (OpenAlex)

Protein Degradation and InhibitorsNanoplatforms for cancer theranosticsUbiquitin and proteasome pathwaysComputational Drug Discovery MethodsHistone Deacetylase Inhibitors ResearchPharmacological Effects of Natural CompoundsAdvanced Drug Delivery SystemsFerroptosis and cancer prognosisAdvanced Nanomaterials in CatalysisPeptidase Inhibition and Analysis

Frequently asked questions about Acta Materia Medica

Is Acta Materia Medica a predatory journal?

PubScope has no integrity flags on record for Acta Materia Medica: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 84/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Acta Materia Medica?

Acta Materia Medica is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 1.133.

Is Acta Materia Medica indexed in Scopus and Web of Science?

Acta Materia Medica is indexed in Scopus, DOAJ.

What is the aims and scope of Acta Materia Medica?

How much does it cost to publish in Acta Materia Medica?

Acta Materia Medica is a Diamond open-access journal — there is no article processing charge (APC) to publish.